Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. Jan. 18, 2019. George Savage.

Executive Summary

Proteus Digital Health announced a new partnership with Minneapolis-based Fairview Health Services and the University of Minnesota Health to prescribe "digital capecitabine," encapsulating the common chemotherapy drug with Proteus' sensor, to colorectal cancer patients. The goal is to achieve medication adherence, leading to enhanced treatment and outcomes, through home-based monitoring. See what George Savage, Proteus' co-founder and chief medical officer, had to say about the new digital oncology program here.

"What we find in the real world is that most patients aren't able to tolerate the (full eight cycles of chemotherapy) due to adverse events and other issues. By adding digital feedback to the physician and to the patient, we're hoping to support the patients in taking the med appropriately. The tool can help the physician "see how the patient is doing in a more granular way to hopefully prevent these sorts of things that would lead to hospital admission and cessation of the chemotherapy early."—George Savage, chief medical officer, Proteus Digital Health

Click here for a free trial of Medtech Insight

Related Content

Topics

UsernamePublicRestriction

Register

MT124508

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel